Abstract

ANDREU, José Manuel et al. Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence. Arch. Cardiol. Méx. [online]. 2012, vol.82, n.3, pp.248-251. ISSN 1665-1731.

Current recommendation is to add antiplatelet drug to oral anticoagulation in patients with atrial fibrillation (AF) and vascular disease. However, it is debatable to join both antithrombotic drugs in stable vascular disease.

Keywords : Atrial fibrillation; Aspirin; Oral anticoagulation; Vascular disease; Spain.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )